Arcoma ABOSTO:ARCOMA 75 Days Payable is 85.66 as of Mar. 2026, which is 15% above its 10-year median of 74.60. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.86 (Fairly Valued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Arcoma AB ranks better than 59.37% on this metric.
Arcoma AB's average Accounts Payable for the
three
months ended in Mar. 2026 was kr17.5 Mil. Arcoma AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr18.7 Mil.
Hence, Arcoma AB's Days Payable for the
three
months ended in Mar. 2026 was 85.66.
The historical rank and industry rank for Arcoma AB's Days Payable or its related term are showing as below:
OSTO:ARCOMA'
s Days Payable Range Over the Past 10 Years
Min: 69.06 Med: 74.6 Max: 91.93
Current: 86
During the past 13 years, Arcoma AB's highest Days Payable was 91.93. The lowest was 69.06. And the median was 74.60.
OSTO:ARCOMA's Days Payable is ranked better than 59.37% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs OSTO:ARCOMA: 86.00
Arcoma AB's Days Payable
declined
from Mar. 2025 (88.51) to Mar. 2026 (85.66).
It may suggest that Arcoma ABaccelerated paying its suppliers.
Arcoma AB Days Payable Related Terms
Arcoma AB Days Payable Historical Data
* Premium members only.
The historical data trend for Arcoma AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ARCOMA vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Arcoma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcoma AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Arcoma AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Arcoma AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcoma AB (OSTO:ARCOMA) has a Days Payable of 85.66 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arcoma AB and its competitors. This is 15% above median its historical median of 74.60. Over the past decade, Arcoma AB's Days Payable has ranged from 69.06 to 91.93. According to the industry distribution chart, Arcoma AB ranks #323 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 40.6%.
Is Arcoma AB's Days Payable too high?
Arcoma AB's current Days Payable of 85.66 is 15% above median its 10-year median of 74.60. Over the past 10 years, this metric has ranged from a low of 69.06 to a high of 91.93. The Medical Devices & Instruments industry median Days Payable is 68.07. Arcoma AB's value of 85.66 is 25.8% above this industry median. Based on the distribution chart, Arcoma AB ranks #323 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #323 out of 795 companies for Days Payable. This puts Arcoma AB in the upper half of its industry. The industry median Days Payable is 68.07. Arcoma AB's value of 85.66 is 25.8% above this benchmark. Historically, Arcoma AB's own Days Payable has ranged from 69.06 to 91.93 over the past decade. While the company's 10-year median is 74.60 vs. the industry median of 68.07, Arcoma AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcoma AB's current Days Payable of 85.66 is 25.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arcoma AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcoma AB's current Days Payable is 85.66, which is 15% above median its own 10-year median of 74.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.86, compared to a current price of kr8.40 — trading 6.9% above its estimated fair value. The current Days Payable is 85.66, which is 15% above median its 10-year median of 74.60 and 25.8% above the Medical Devices & Instruments industry median of 68.07. Arcoma AB's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Days Payable is 85.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued.
The current stock price of kr8.40 is trading 6.9% above its estimated GF Value™ of kr7.86.
GuruFocus considers Arcoma AB to be Fairly Valued.
Key valuation signals for OSTO:ARCOMA:
Days Payable: 85.66 (15% above median its 10-year median of 74.60)
GF Value™: kr7.86 vs. price of kr8.40 (6.9% above fair value)
Industry Position: 25.8% above the Medical Devices & Instruments median (#323 of 795)
No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score
Get the complete analysis for OSTO:ARCOMA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ARCOMA has been successfully added to your 
